ProPhase Labs Inc. (Nasdaq: PRPH), a biotech firm with plans to build a crypto treasury, announced on Sep. 23 that its three COVID-19 testing lab units have filed for reorganization under Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of New Jersey. The bankruptcy action is "strictly" limited to the COVID-19 testing lab units which are collectively owed tens of millions of dollars by insurance companies, the statement read. The goal of the bankruptcy filing is to accelerate recovery ...